Viper Equity Partners Continues Its Domination of the Oral Surgery Gold Rush
After securing over 150m dollars in transactions boasting 30m in EBITDA so far in 2021 Viper Equity Partners predicts continued heavy buying in.
Industry News
Science and Medicine
New Risk Factors for Chronic Skin Cancer
It’s not something at the moment we can cure. It’s something that we need to monitor continually so that when these cancers crop.
